Mirabelli Mary
SEC CIK 1937525 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GNLX | GENELUX Corp | Dir | 102.7K | — | — | 6 | 2023-02-17 | 2026-06-16 |
Most active insiders at GNLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zindrick Thomas | Pres, CEO | — | $117.7K |
| 2 | Thomas John | Dir | — | $108.8K |
| 3 | Smither John W | Dir | — | $34.9K |
| 4 | Cappello Joseph | Chief Technical Off | — | $34.0K |
| 5 | Yu Yong | SVP, Clinical Development | — | $32.6K |
| 6 | Smalling Ralph | Head of Regulatory | — | $2,804 |
| 7 | Pulisic Matthew | CFO | — | — |
| 8 | Mirabelli Mary | Dir | — | — |
| 9 | Groen Eric | GC | — | — |
| 10 | Tyree James L | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 19:05 | 2026-06-16 | GNLX | GENELUX Corp | Mirabelli Mary | Dir | A - Grant | $0.00 | +28.4K | 102.7K | +38% | $0 |
| D | 2025-08-29 | 2025-08-27 | GNLX | GENELUX Corp | Mirabelli Mary | Dir | A - Grant | $0.00 | +22.3K | 73.3K | +44% | $0 |
| D | 2024-08-05 | 2024-08-01 | GNLX | GENELUX Corp | Mirabelli Mary | Dir | A - Grant | $0.00 | +39.5K | 52.0K | +317% | $0 |
| D | 2024-06-07 | 2024-05-29 | GNLX | GENELUX Corp | Mirabelli Mary | Dir | P - Purchase | — | +8,000 | 12.5K | +179% | — |
| D | 2023-09-13 | 2023-09-11 | GNLX | GENELUX Corp | Mirabelli Mary | Dir | A - Grant | $0.00 | +3,460 | 4,460 | +346% | $0 |
| 2023-05-02 | 2023-02-17 | GNLX | GENELUX Corp | Mirabelli Mary | Dir | A - Grant | $0.00 | +1,000 | 1,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations